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cally for CRC.
Keywords Diet · anti-inflammatory agents · Colorectal 
cancer · survival · Determinant
Abbreviations
aRg  arginase
CRC  Colorectal cancer
CRP  C-reactive protein
DII  the Dietary Inflammatory Index
Il  Interleukin
IQR  Inter-quartile range
MUFa  Monounsaturated fatty acids
tnF  tumor necrosis factor
Introduction
Inflammation has been recognized as an important prop-
erty of several chronic conditions. It has been observed that 
several inflammatory biomarkers, that is, Il-1β, Il-4, Il-6, 
Il-10, tnF-α and C-reactive protein (CRP) are poten-
tial markers of increased risk of cardiovascular endpoints 
(Koenig 2013; halcox et al. 2014), metabolic syndrome 
(Fuentes et al. 2013), lung (guo et al. 2013) and colorectal 
cancer (CRC) (Wu et al. 2013; song et al. 2013), and some 
other chronic diseases (Iyengar et al. 2013; Rodriguez-her-
nandez et al. 2013).
Diet is one of a key element of individual’s lifestyle 
responsible for the development of chronic diseases. For 
the last few years, an increased interest in diet as a deter-
minant related to, and even causally associated with, the 
level of inflammation has been observed. Dietary pat-
terns have been linked with some biomarkers of low-grade 
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Purpose Prolong inflammation is a central process 
observed in several chronic conditions and may be respon-
sible for survival. there is an increasing evidence showing 
the role of diet in inflammation and habitual diet may be 
responsible for low-grade inflammation. the purpose of 
our study was to assess the effect of inflammatory proper-
ties of habitual diet measured by the Dietary Inflammatory 
Index (DII) on survival among surgical patients treated for 
colorectal cancer (CRC).
Methods a follow-up study among 689 CRC patients 
(mean age 58 years, ±8.9; 56.7 % males) treated surgically 
was performed in Krakow, Poland. habitual diet was assessed 
by a standardized semiquantitative food frequency question-
naire. next, 23 dietary items were used to calculate DIIs. Vital 
records were verified to determine status of the participants.
Results study has shown linear association between 
DII and survival time among CRC patients with totally 
removed cancer treated by chemotherapy (b = −0.13, 
p = 0.024). after adjustment for several important covari-
ates, DII was associated with survival during up to 3 years 
after surgery, but only in patients without distant metasta-
ses (3-year hRDII>−2.27 = 0.61, 95 % CI 0.38–0.99).
Conclusions the results of the investigation have shown 
the usefulness of the DII as a potential predictor of survival 
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inflammation (Barbaresko et al. 2013). Western type diet 
was associated with an increase in CRP, Il-6 and serum 
amyloid a, whereas ‘healthy type’ diet (high in fruits, veg-
etables, tomato, poultry, legumes, tea, fruit juices and whole 
grains), oppositely, was related with a decrease in inflamma-
tory markers (esmaillzadeh et al. 2007). Mediterranean diet 
was also assessed (estruch 2010), and there are publications 
showing a decrease in inflammatory cytokines related to the 
increase in intake of polyunsaturated fatty acids (Calviello 
et al. 2013), vitamins (van herpen-Broekmans et al. 2004) 
and fruits and vegetables (Root et al. 2012).
Dietary components such as macronutrients, vitamins, 
minerals, and trace elements may modulate the course of 
body inflammation and thus may change a response to 
injury and infection. this effect was investigated for the 
last years especially among malnourished patients, and it 
was found that diet rich in n-3 fatty acids, arginine, glu-
tamine and vitamins C and e improves clinical outcomes 
and decreases the frequency of infections and infectious 
complications among surgical patients (Klek et al. 2011; 
Marano et al. 2013). this effect, however, is discussible 
among well-nourished patients, and results are not consist-
ent (Barker et al. 2013; Falewee et al. 2013).
Clinical dietary intervention may improve the effective-
ness of treatment; therefore, it is also reasonable to con-
sider habitual diet as one of determinants of health out-
comes. the assessment of habitual diet is very challenging. 
Diet is a very complex phenomenon. It includes beneficial 
and unfavorable constituents, and their interrelation may 
be responsible for the final effect. One of the solutions is a 
proposal to create a scoring system to assess general prop-
erties of diet. there are several dietary scores published 
to date; however, they have not been validated in terms 
either to assess inflammatory properties or to predict some 
inflammatory-related health outcomes. the solution may 
be the Dietary Inflammatory Index (DII) (Cavicchia et al. 
2009). the DII is the first literature-based index to focus 
primarily on the inflammatory properties of diet. the Index 
considers pro- and anti-inflammatory dietary constituents 
and creates the net value, so it benefits by the assessment 
of general properties of diet, and thus, it seems to prepon-
derate other scores as the alternate healthy eating Index 
or the alternate Mediterranean Diet Index. the DII is not 
dependent on the population means or on the recommen-
dations of intake, and it is not limited only to macronutri-
ents and micronutrients, but also considers commonly con-
sumed components of diet including spices, tea and others 
(Cavicchia et al. 2009).
the inflammation is a central process in majority dis-
eases, and available evidence has shown that dietary habits 
are related to the level of inflammatory cytokines; there-
fore, we tried to investigate a long-term effect of dietary 
habits among CRC patients.
Purpose
the purpose of the study was to assess the effect of inflam-
matory properties of habitual diet (understood as prolong 
exposure to low-grade inflammation) measured by the DII 
on survival among surgical patients treated for CRC.
Materials and methods
study design and sample
a follow-up prospective cohort study included CRC 
patients admitted to the I Chair of general surgery and 
Department of gastroenterological surgery, Jagiellonian 
University Medical College, Krakow, Poland. the study 
was conducted between 2010 and 2013. Individuals eli-
gible for the research were cases recruited primarily for 
a case-control investigation performed between 2000 and 
2008 (projects 6 P05D 00220 and 2 P05D 05329) and 
between 2010 and 2013 (project no. n404 034039). the 
study design has been described elsewhere (galas et al. 
2013; Jedrychowski et al. 2009). In brief, participants were 
newly diagnosed incident cases of sporadic adenocarci-
noma of either colon or rectum. Inclusion criteria were 
age of up to 75 years, Caucasian, being a native Polish, 
referred to a surgical treatment of CRC. exclusion criteria 
were the following: a presence of communication (verbal 
contact) problems and/or cognitive limitations or a diag-
nosis of any of the following: hereditary non-polyposis 
CRC, familiar adenomatous polyposis, attenuated familial 
adenomatous polyposis, mixed polyposis syndrome, ash-
kenazi colon cancer, hereditary breast and CRC or any of 
hamartomatous polyposis syndromes, moreover, a diag-
nosis of secondary cancer (its distant metastasis in large 
bowel), a diagnosis of primary cancer other than colo-
rectal, a recurrent cancer or underwent surgery (before 
recruitment) of gastrointestinal tract, present or past diag-
nosis of chronic disease of gastrointestinal tract (diver-
ticulitis, irritable bowel syndrome, acute or chronic gas-
tric ulcer, acute/chronic pancreatitis), diabetes (any type), 
renal failure, hepatic insufficiency or a presence of pro-
longed gastrointestinal symptoms. the diagnosis of colon 
either rectal cancer in all study participants was confirmed 
histopathologically.
In total, 703 cases were recruited for the study. next, 
14 subjects were excluded from the analyses due to lack 
of information about lifestyle factors (not willing to fin-
ish an interview), a refusal to undergo surgery treatment, 
no access to detailed information about hospitalization 
or being a patient admitted for reoperation. Finally, the 
remaining 689 cases (98.0 % of the recruited sample) were 
analyzed.
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tools and data collection
study participants were interviewed after the admission 
to the hospital, but before surgery about their dietary hab-
its, some demographic characteristics and other potential 
covariates. Clinical information was collected from hospi-
tal medical records. Dietary habits were assessed by a sem-
iquantitative food frequency questionnaire (sFFQ) devel-
oped in cooperation with the german Cancer Research 
Centre, during introductory part of the european Prospec-
tive Investigation into Cancer and nutrition (ePIC-Pots-
dam) project. In total, 148 dietary items were used includ-
ing questions about consumption of cereals, dairy products, 
bread, type and cuts of meat and fish, fresh fruits (summer/
winter time), salads and fresh and cooked vegetables, rice 
or pasta, soups, sweets, baked goods, drinks and others. 
For each food or beverage item, a commonly consumed 
portion size was specified by standardized photographs. 
next, respondents were asked to provide information about 
frequency of consumption. For the research, information 
about usual (habitual) consumption over the period of 
1 year by calendar seasons was gathered by trained inter-
viewers. Patient cases were asked about their dietary pat-
terns at a time of 5 years prior to the onset of gastrointes-
tinal symptoms (if present) or prior to the beginning of the 
diagnosis process; this was done to assess a habitual dietary 
pattern of participants. Dietary data were recalculated using 
Polish food composition tables to obtain information about 
an average consumption of dietary macro- and micronu-
trients (Kunachowicz et al. 1998; nadolna et al. 2000). 
the validity and reproducibility of the questionnaire was 
assessed and was published elsewhere (Bohlscheid-thomas 
et al. 1997a, b).
Inflammatory properties of diet have been assessed by 
the DII developed by Cavicchia and coworkers (Cavicchia 
et al. 2009). the DII considers different nutritional data, 
including caloric intake, consumption of different bever-
ages and alcoholic drinks, intake of macro and micronutri-
ents, including vitamins, microelements and others. Dietary 
data collected in the current investigation allow calculation 
of the following: an average intake of energy, drinking of 
tea, consumption of caffeine, different alcoholic drinks 
such as wine, beer and liquor (for the purpose of the study, 
wine and beer consumption was considered directly, and 
other sources of alcohol such as fruit wine, sparking wine 
and vodka were recalculated according to their content of 
pure alcohol, and as thus they were used in the calculation 
of the DII) and intake of carbohydrates, fiber, fat, n-3 and 
n-6 fatty acids, monounsaturated fatty acids (MUFa), satu-
rated fatty acids, protein, cholesterol, vitamin a, thiamin, 
riboflavin, niacin, vitamin C, vitamin e, β-carotene and 
iron. all in all, it was possible to obtain the DII based on 
the 23 different dietary items in our study. the DII measure 
was obtained as a sum of adjusted scores as they were pub-
lished by Cavicchia et al. (2009) (see “appendix”), and 
finally, it provided the average habitual DII for every indi-
vidual studied. higher DII described better diet, meaning 
with a lower content of pro-inflammatory and a higher con-
tent of anti-inflammatory dietary components.
survival
Vital records were used to determine participants’ status, 
and the date of death was collected for every deceased 
patient. Vital status was verified three times between 2010 
and 2013, and the last check took place in May 2013 and 
covered deaths occurring until the end of January 2013.
Covariates
Considering that survival rate among patients treated for 
CRC is determined by several factors, several covariates 
were used for adjustment, including: (1) age in years (con-
sidered as continuous variable); (2) marital status (married 
or other); (3) overweight or obesity (understood as body 
mass index ≥25 kg/m2); (4) smoking status at a time of 
surgery (non-smoker, ex-smoker or active smoker); (5) cal-
endar year when surgery was performed; (6) surgery type 
(radical or palliative); (7) cancer site (colon or rectum); (8) 
chemotherapy after surgery (yes/no); (9) radiotherapy after 
surgery (yes/no).
statistical analysis
as a first step of investigation, the DII for every individual 
was calculated as described above. next, to provide basic 
characteristics of the study group, general descriptive data 
and differences across groups of patients who survived 
and those who died during the study period have been 
presented. In order to test differences between groups, the 
normality of the distribution for continuous variables was 
tested by shapiro–Wilk test. as the distributions were not 
normal, the U-Mann–Whitney test was used to assess sig-
nificance. Characteristics in categorical scale were com-
pared across groups by the Chi-square test, because every 
expected count was higher than five. the main determinant 
of survival is the presence of distant metastases, thus a role 
of low-grade dietary-related inflammation (measured by the 
DII) was investigated separately among patients without 
and patients with metastases. In order to estimate hazard 
ratios (hRs) multivariable Cox’s regression models were 
used. hRs were assessed for 1-, 3- and 5-year observation 
period as well as for the whole follow-up. Because the DII 
is a relatively new index, it was tested as a continuous and 
as a categorical variable with a cutoff equal to the median 
observed in the group of survivors. Finally, Kaplan–Meier 
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survival curves and nelson-aalen cumulative hazard func-
tions for death have been drawn to show graphically the 
differences between DII groups over time.
the study was conducted in accordance with the ethical 
principles of the Declaration of helsinki and was approved 
by the Bioethical Committee of Jagiellonian University 
(number KBet/115/B/2011).
the analyses were done by the stata/IC 11.1 for Win-
dows (64-bit × 86-64) stataCorp lP software. Results with 
the p < 0.05 were considered statistically significant.
Results
the cohort comprised 689 patients included in the analy-
sis for follow-up study. all observed subjects accounted for 
3,180.31 person-years. three hundred and nine (44.8 %) 
patients died during the study time. there were 56.7 % of 
men in the study group. gender distribution across groups 
was almost the same among deceased and alive patients. 
Considering background characteristics, patients who died 
were at similar age to survivors, but had different distribu-
tion of smoking (higher proportion of current smokers: 27.8 
vs. 22.9 %), had more frequently distant metastases (51.5 
vs. 5.0 %), more frequently underwent palliative surgery 
(17.5 vs. 1.8 %) and in higher proportion were referred to 
postsurgical chemotherapy (83.8 vs. 55.3 %) (table 1).
the DII was used to assess the role of diet as a pos-
sible determinant of survival. Overall, the mean DII was 
−2.66 (sD = 2.43) and median: −2.42 (IQR −3.91 
to −1.15) with a slightly higher mean value observed 
among survivors. as the DII was expected to predict 
survival time after surgical treatment, we decided to use 
linear regression to test the association between the DII 
and the survival time. We performed the analysis among 
all patients who died during study time, and the result 
was not significant (p = 0.174). Considering that some 
characteristics might influence survival time, subse-
quently we limited a sample to the group of these who 
underwent total surgery and were treated with chemo-
therapy. Consequently, we observed a linear association 
between the DII and the survival time (an increase by 
0.13 years in survival for every increase in the DII by 1 
point; p = 0.024) (Fig. 1).
Finally, we used Cox regression models to assess the 
role of the DII as a possible determinant of survival. after 
adjustment for important covariates, we have found that 
the risk of death was decreased among patients without 
distant metastases and with higher DIIs during 1 year after 
surgery if the DII was considered either as a continuous 
(hR = 0.87; p = 0.048) or as a categorical variable (1-year 
hRDII>−2.27 = 0.40; p = 0.050). after 3-year time the risk 
was still decreased for the patients with the DII above the 
median (3-year hRDII>−2.27 = 0.61; p = 0.046) (table 2). 
the effect of the DII was not observed among patients with 
distant metastases, independently from the period of time.
Discussion
Our study showed the beneficial effect of a long-term adult 
exposure to diet with lower pro-inflammatory properties 
(measured by the DII) among CRC patients treated surgi-
cally who had no distant metastases at the time of diagno-
sis and treatment. the association was observed in the first 
year after surgery and persisted until the third year. these 
results are consistent with our expectations. In our study, 
we were able to assess habitual diet before surgery, so the 
effect (if present) should be observed during relatively short 
period after surgical treatment. additionally, the effect of 
diet as a determinant of death among CRC patients was 
supposed to be weak in the presence of distant metastases; 
therefore, the lack of an effect among patients in stage IV 
was not surprising.
the analysis of Kaplan–Meier survival curves (Fig. 2) 
has shown that the role of inflammatory properties of 
diet may have a long lasting effect (meaning longer than 
3 years), but the reduction in sample size limited the possi-
bility to prove it in a statistical way. the long lasting effect 
is also suggested by the nelson-aalen cumulative hazard 
functions (Fig. 3).
although the presented concept is new, our results are 
strengthened by the cohort prospective design, an ability 
to include relatively large number of patients and a pos-
sibility to adjust for a large number of important covari-
ates as age, smoking status, a type of surgery, cancer site, 
chemo and radiotherapy after surgery. additionally, we 
considered the possibility of ‘the cohort effect’ related 
to the fact that patients treated in different calendar peri-
ods might undergo slightly different treatments due to 
some improvements in medical procedures. therefore, 
our results were also controlled for a calendar year when 
patients were treated. We decided also to use a proxy 
measure (as marital status) of some social circumstances, 
which might determine the quality of care and the ability 
to fulfill treatment regimen after hospitalization. Finally, 
we used the presence of overweight and obesity as a 
covariate, because it was observed that an adipose tissue, 
particularly visceral fat, releases some pro-inflammatory 
cytokines, such as CRP, interleukin-6 (Il-6) and tumor 
necrosis factor-alpha (tnF-α) (Kwon and Pessin 2013), 
and in that way overweight and obesity might confound 
the relationship.
Our study has shown a decrease in the risk of death 
among patients with higher DII. these results require 
some elucidation. Firstly, we have noticed the effect only 
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among patients without metastases, and the linear asso-
ciation was observed if patients were limited to those 
who had surgically removed cancer treated by chemo-
therapy. this is consistent with the concept that expo-
sure to worse diet resulting in prolong low-grade inflam-
mation may lead to a decrease in body defense and, as 
a consequence, may limit a possibility to maintain rela-
tively good health during chemotherapy. Preventing and 
treating the toxicities of chemotherapy remains a major 
challenge for cancer treatment, and the general patient’s 
health condition related to the experiences before sur-
gery may play a crucial role. the concept is also con-
sistent with the results of some animal studies, showing 
that consumption of long-chain omega-3 fatty acids 
improved the therapeutic index of some cancer drugs 
(hardman et al. 2002).
the role of inflammation among surgical patients 
has been investigated for several years. It was found that 
inflammatory status is among important markers of hospi-
tal morbidity and mortality. Consequently, immunomodu-
lating diet was proposed as an intervention to improve clin-
ical outcomes (Klek et al. 2011; Marano et al. 2013; Barker 
et al. 2013; Falewee et al. 2013; hubner et al. 2012). there 
are also studies showing the role of inflammatory markers 
in survival. an elevated CRP was linked with poorer sur-
vival in CRC patients receiving adjuvant chemotherapy 
Table 1  Basic characteristics of the study group across vital status during study period
Chi-square test, MW the U-Mann–Whitney test
total
[n = 689]
alive
[n = 380]
Died
[n = 309]
p
Males [%, (n)] 56.7 % (391) 56.3 % (214) 57.3 % (177) df = 1
pChi = 0.935
age (years)
 Mean (sD) 58.0 (8.9) 58.1 (8.8) 57.9 (9.1)
 Median, Q1–Q3 59 (52–65) 59 (52–65) 59 (53–65) pMW = 0.910
Married
 Yes 86.5 % (596) 7.9 % (334) 84.8 % (262) df = 1
pChi = 0.236 no 13.5 % (93) 12.1 % (46) 15.2 % (47)
smoking [%, (n)]
 non-smokers 44.1 % (304) 42.1 % (160) 46.6 % (144)
 ex-smokers 30.8 % (212) 35.0 % (133) 25.6 % (79) df = 2
pChi = 0.025 Current smokers 25.1 % (173) 22.9 % (87) 27.8 % (86)
Overweight or obesity  
(BMI ≥25 kg/m2) [%, (n)]
69.5 % (478) 70.2 % (266) 68.6 % (212) df = 1
pChi = 0.655
Dietary Inflammatory Index
 Mean (sD) −2.66 (2.43) −2.57 (2.48) −2.77 (2.37)
 Median, Q1–Q3 −2.42 (−3.91 to −1.15) −2.27 (−3.73 to −1.08) −2.65 (−3.99 to −1.18) pMW = 0.112
Cancer site [%, (n)]
 Colon 48.2 % (332) 47.9 % (182) 48.5 % (150) df = 1
pChi = 0.865 Rectum 51.8 % (357) 52.1 % (198) 51.5 % (159)
Distant metastasis
 no 74.2 % (511) 95.0 % (361) 48.5 % (150) df = 1
pChi < 0.001 Yes 25.8 % (178) 5.0 % (19) 51.5 % (159)
surgery type
 Radical 91.1 % (628) 98.2 % (373) 82.5 % (255) df = 1
pChi < 0.001 Palliative 8.9 % (61) 1.8 % (7) 17.5 % (54)
Chemotherapy [%, (n)]
 no 30.8 % (212) 43.2 % (164) 15.5 % (48)
 Yes 68.1 % (469) 55.3 % (210) 83.8 % (259) df = 2
pChi < 0.001 Referred to but not confirmed 1.2 % (8) 1.6 % (6) 0.7 % (2)
Radiotherapy [%, (n)]
 no 97.7 % (673) 97.9 % (372) 97.4 % (301) df = 1
pChi = 0.675 Yes 2.3 % (16) 2.1 % (8) 2.6 % (8)
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(Crozier et al. 2006). In the nhanes III cohort of 7,072 
individuals, a clinically raised (≥1.00 mg/dl) baseline 
serum CRP was associated with approximately 2.5-times 
greater risk of CRC death (swede et al. 2014). leitch 
observed an increased risk of CRC death across catego-
ries of modified glasgow Prognostic scale among both 
149 CRC patients without distant metastases and 84 CRC 
patients with unresectable colorectal liver metastases 
(hRs = 2.01, and 1.46, respectively) (leitch et al. 2007). 
Read studied 23 CRC stage IV patients referred to chemo-
therapy, and he observed a significant positive correlation 
between survival time and serum concentration of Il-10 
(r = 0.488, p = 0.03) and a negative correlation between 
survival time and a concentration of Il-6 (r = −0.63, 
p = 0.003) (Read et al. 2007). there is also some other evi-
dence showing the role of inflammation in survival among 
CRC patients (Paik et al. 2014; Crozier et al. 2009; nozoe 
et al. 2008).
the effect of inflammatory response to diet is definitely 
weaker than the response to the presence of a clinical dis-
ease and surgical treatment, which are determinants of 
inflammatory state before and after surgery. that is why 
we considered diet as an adult lifetime exposure respon-
sible for the deterioration of a general condition among 
cancer patients rather than a point in time factor related to 
survival.
Fig. 1  Univariable linear regression between the DII and survival 
time among patients who died during observation period [n = 215, 
survival time (years = 2.95 + 0.13 × DII; p = 0.024]. *analysis 
limited to patients who underwent total surgery and were treated by 
chemotherapy
Table 2  hazard ratios (hRs) of death during different observation period after CRC surgery depending on the inflammatory properties of diet 
measured by the DII
Multivariable Cox regression models—all estimations (models) were adjusted for age [years], smoking status [non-smoker, ex-smoker, current 
smoker], marital status [married, other], overweight or obesity [yes/no], calendar year when surgery was performed, surgery type [palliative/radi-
cal], cancer site [colon/rectum], chemotherapy after surgery [yes/no], radiotherapy after surgery [yes/no]
a One patient has been excluded from the analysis due to no information regarding anthropometric measurements (the presence of overweight or 
obesity)
DII [continuous] DII [>−2.27 vs. ≤−2.27]
1st year 3 years 5 years Overall 1st year 3 years 5 years Overall
Patients without distant metastasesa
 total number of observa-
tions
510 510 510 510 510 510 510 510
 number of failures  
[n, (%)]
23 (4.5 %) 79 (15.5 %) 125 (24.5 %) 150 (29.4 %) 23 (4.5 %) 79 (15.5 %) 125 (24.5 %) 150 (29.4 %)
 total time at risk  
(person-years)
480.96 1,287.37 1,926.53 2,906.10 480.96 1,287.37 1,926.53 2,906.10
 hR 0.87 0.92 0.97 0.98 0.40 0.61 0.70 0.76
 95 % CI 0.75–0.999 0.85–1.009 0.90–1.04 0.92–1.05 0.16–1.000 0.38–0.99 0.48–1.02 0.55–1.08
 p 0.048 0.079 0.366 0.629 0.050 0.046 0.062 0.130
Patients with distant metastases
 total number of  
observations
178 178 178 178 178 178 178 178
 number of failures  
[n, (%)]
68 (38.2 %) 151 (84.8 %) 159 (89.3 %) 159 (89.3 %) 68 (38.2 %) 151 (84.8 %) 159 (89.3 %) 159 (89.3 %)
 total time at risk  
(person-years)
141.60 236.89 258.96 274.21 141.60 236.89 258.96 274.21
 hR 1.10 1.01 1.003 1.003 1.43 1.09 1.06 1.06
 95 % CI 0.98–1.25 0.94–1.09 0.93–1.08 0.93–1.08 0.85–2.39 0.78–1.52 0.76–1.48 0.76–1.48
 p 0.112 0.776 0.927 0.927 0.175 0.628 0.727 0.727
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Dietary habits as a determinant of low-grade inflam-
mation may play a role through its effect on levels of pro-
inflammatory cytokines. another possible explanation is that 
low-grade diet-related inflammation may be directly asso-
ciated with the aRg1 pathway. It was observed that within 
hours of physical injury, large number of arginase-1 (aRg1)-
expressing immature myeloid cells (IMCs) accumulate in the 
spleen and other lymphoid tissue (Makarenkova et al. 2006). 
these cells inhibit t lymphocyte growth and function, result-
ing in impairment of t cell proliferative response (Zhu et al. 
2010). the preventive goal in this situation is to minimize the 
immunosuppression and to promote healing and tissue repair 
that is the rationale for immunomodulating diet suspected to 
improve surgical outcomes. Prolonged, low-grade inflamma-
tion may lead to the lack of reserves on a sub-clinical level, 
and after surgery and chemotherapy, it may be a risk factor 
for unfavorable outcomes among patients.
Our investigation is not free from limitations. Diet is con-
stituted by much more than 23 dietary items we were able 
to consider. nevertheless, we would like to mention that we 
included all relevant—those which are the main dietary com-
ponents in our country. next, we have considered habitual 
diet before surgery. as it is consistent with the concept of the 
life course approach (meaning the study of ‘person’s experi-
ences over a life time that can have cumulative effects on their 
health’), after digestive tract surgery, patients usually change 
their diet. In our study, we had no data about dietary habits 
after surgery, which might also influence the survival. Moreo-
ver, pre- and post-surgery inflammatory response might also 
determine long-term consequences, but data about inflamma-
tory markers were not available in our study either.
In summary, our investigation of the inflammatory 
properties of habitual diet using the DII as a predictor of 
survival among CRC patients is novel to our knowledge, 
and it provides a new insight into the role of diet. the 
results of the current research have shown the usefulness 
of the DII developed by Cavicchia as a potential predic-
tor of survival among patients without distant metastases 
treated surgically for CRC. Moreover, by more complex 
assessment of the role of diet considering its inflammatory 
properties, it provides the evidence for the role of dietary 
habits, and if confirmed by other investigations, that may 
explain some heterogeneity in patients’ survival outcomes.
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